Understanding the precise role of KIF4A in LN metastasis and tumor progression of BC and in activation of the CXCL5/MDSC axis will not only increase our knowledge of MDSC-induced tumor progression but also enable the development of a therapeutic strategy for bladder cancer progression. Here, KIF4A is linked to urinary bladder carcinoma.